-transparent.png){kind=logo}
A double blind crossover study was planned in order to compare the effects of oestrogen, progestogen and placebo on hot flushes. The 49 women studied had previously undergone hysterectomy and bilateral oophorectomy. The drug regimen consisted of three months each of ethinyl oestradiol 50 microgram/day, d norgestrel 250 microgram/day, a combination of these two substance ("Nordiol") and a placebo. The predominant reason for requesting a change of medication was intolerable hot flushes associated with placebo use. All hormonal preparations were found to be significantly more effective than placebo in reducing hot flush frequency and intensity. Oestrogen containing medications were more effective than the progestogen (norgestrel).
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
July 2018,
European journal of clinical nutrition,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
January 1981,
European journal of clinical pharmacology,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
February 1983,
The Australian & New Zealand journal of obstetrics & gynaecology,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
March 1986,
The Medical journal of Australia,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
January 1984,
Current medical research and opinion,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
January 1975,
Acta obstetricia et gynecologica Scandinavica,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
May 2017,
Lancet (London, England),
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
December 1968,
Journal of reproduction and fertility. Supplement,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
February 2009,
Climacteric : the journal of the International Menopause Society,
L Dennerstein, and
G D Burrows, and
G Hyman, and
C Wood
February 1979,
Maturitas,
